flucytosine has been researched along with Sporotrichosis in 20 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Sporotrichosis: The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound with SPOROTHRIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "Intravenous miconazole, an investigational, broad-spectrum, antifungal imidazole drug, was clinically effective when used for the first time in a patient with life-threatening sporotrichosis." | 7.65 | Pulmonary sporotrichosis: Treatment with miconazole. ( Archer, G; Rohwedder, JJ, 1976) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "Intravenous miconazole, an investigational, broad-spectrum, antifungal imidazole drug, was clinically effective when used for the first time in a patient with life-threatening sporotrichosis." | 3.65 | Pulmonary sporotrichosis: Treatment with miconazole. ( Archer, G; Rohwedder, JJ, 1976) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| "Sporotrichosis is a subcutaneous and chronic infection caused by traumatic inoculation of pathogenic sporothrix species, usually infecting the skins and subcutaneous tissues of humans and animals." | 1.91 | Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China. ( Cai, W; Fang, J; Huang, J; Li, J; Lin, L; Lu, S; Zhang, J, 2023) |
| "Although blastomycosis is endemic in North America, only 4 cases have been identified in Natal during the last 25 years, and all presented with atypical clinical features." | 1.28 | Tropical mycoses. ( Bayles, MA, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (60.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarado-Ramírez, E | 1 |
| Torres-Rodríguez, JM | 1 |
| Marimon, R | 1 |
| Serena, C | 1 |
| Gené, J | 1 |
| Cano, J | 1 |
| Guarro, J | 1 |
| Lin, L | 1 |
| Huang, J | 1 |
| Fang, J | 1 |
| Li, J | 1 |
| Cai, W | 1 |
| Zhang, J | 1 |
| Lu, S | 1 |
| Córdoba, S | 1 |
| Isla, G | 1 |
| Szusz, W | 1 |
| Vivot, W | 1 |
| Hevia, A | 1 |
| Davel, G | 1 |
| Canteros, CE | 1 |
| Kantarcioğlu, AS | 1 |
| Boekhout, T | 1 |
| De Hoog, GS | 1 |
| Theelen, B | 1 |
| Yücel, A | 1 |
| Ekmekci, TR | 1 |
| Fries, BC | 1 |
| Ikeda, R | 1 |
| Koslu, A | 1 |
| Altas, K | 1 |
| Shelley, WB | 1 |
| Sica, PA | 1 |
| Beardmore, GL | 1 |
| Utz, JP | 2 |
| Rohwedder, JJ | 1 |
| Archer, G | 1 |
| Barfuss, T | 1 |
| Seeliger, HP | 1 |
| Plempel, M | 1 |
| Stretcher, GS | 1 |
| Smith, JG | 1 |
| Bayles, MA | 1 |
| Van Cutsem, J | 1 |
| Meyer, RD | 1 |
| Riley, HD | 1 |
| Newberry, WM | 1 |
| Abernathy, RS | 1 |
| Block, ER | 1 |
| Jennings, AE | 1 |
| Bennett, JE | 1 |
2 reviews available for flucytosine and Sporotrichosis
| Article | Year |
|---|---|
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Drug treatment of the systemic mycoses.
Topics: Actinomycosis; Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidi | 1972 |
18 other studies available for flucytosine and Sporotrichosis
| Article | Year |
|---|---|
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazo | 2007 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Sp | 2008 |
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
Topics: Amphotericin B; Animals; Antifungal Agents; China; Flucytosine; Humans; Itraconazole; Microbial Sens | 2023 |
Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Topics: Animals; Antifungal Agents; Argentina; Calmodulin; Flucytosine; Humans; Itraconazole; Microbial Sens | 2018 |
Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Base Sequence; Cryptococcosis; Cryptococcus; Diagnosi | 2007 |
Disseminate sporotrichosis of skin and bone cured with 5-fluorocytosine: Photosensitivity as a complication.
Topics: Adult; Amphotericin B; Bone Diseases; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Male | 1983 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Recalcitrant sporotrichosis: a report of a patient treated with various therapies including oral miconazole and 5-fluorocytosine.
Topics: Administration, Oral; Adult; Amphotericin B; Cautery; Cryosurgery; Curettage; Cytosine; Dermatomycos | 1979 |
The current status of chemotherapeutic agents for the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clotrimazole; Flucytosine; Humans; Miconazole; Myc | 1977 |
Pulmonary sporotrichosis: Treatment with miconazole.
Topics: Amphotericin B; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combinat | 1976 |
[Further experimental data on clotrimazole: effectiveness against Cryptococcus neoformans, Sporothrix schenkii and Blastomyces dermatitidis Gilchrist].
Topics: Amphotericin B; Animals; Blastomyces; Clotrimazole; Cryptococcosis; Cryptococcus; Cryptococcus neofo | 1975 |
Diagnosis and treatment of cutaneous fungus diseases.
Topics: Actinomycosis; Amphotericin B; Blastomycosis; Candida albicans; Candidiasis, Cutaneous; Chromoblasto | 1975 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Chemotherapy of the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; H | 1973 |
Systemic mycoses in children. II.
Topics: Actinomycosis; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; | 1972 |
Treatment of systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cr | 1973 |
Experimental therapy of cladosporiosis and sporotrichosis with 5-fluorocytosine.
Topics: Animals; Antifungal Agents; Cytosine; Flucytosine; Male; Mice; Mitosporic Fungi; Mycoses; Sporotrich | 1973 |